Stoter G - Search Results

1

Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.

de Wit R, van der Burg ME, van den Gaast A, Logmans A, Stoter G, Verweij J. de Wit R, et al. Among authors: stoter g. Ann Oncol. 1994 Sep;5(7):656-7. doi: 10.1093/oxfordjournals.annonc.a058942. Ann Oncol. 1994. PMID: 7993845 Free article. Clinical Trial.

2

Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.

Jansen RL, van der Burg ME, Verweij J, Stoter G. Jansen RL, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1131-3. doi: 10.1016/0277-5379(87)90145-3. Eur J Cancer Clin Oncol. 1987. PMID: 3115787

3

Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer.

Dees A, Verweij J, van Putten WL, Stoter G. Dees A, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1343-7. doi: 10.1016/0277-5379(87)90118-0. Eur J Cancer Clin Oncol. 1987. PMID: 3119346

4

Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy.

van der Burg ME, Lammes FB, van Putten WL, Stoter G. van der Burg ME, et al. Among authors: stoter g. Gynecol Oncol. 1988 Jul;30(3):307-12. doi: 10.1016/0090-8258(88)90244-2. Gynecol Oncol. 1988. PMID: 3164697

5

5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.

van der Gaast A, Verweij J, Planting AS, Stoter G. van der Gaast A, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1988 Apr;24(4):765-8. doi: 10.1016/0277-5379(88)90312-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383976

6

Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.

van der Gaast A, Verweij J, Planting AS, Hop WC, Stoter G. van der Gaast A, et al. Among authors: stoter g. J Clin Oncol. 1995 Jul;13(7):1720-5. doi: 10.1200/JCO.1995.13.7.1720. J Clin Oncol. 1995. PMID: 7541451 Clinical Trial.

7

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.

Bontenbal M, Planting AS, Verweij J, de Wit R, Kruit WH, Stoter G, Klijn JG. Bontenbal M, et al. Among authors: stoter g. Breast Cancer Res Treat. 1995 May;34(2):185-9. doi: 10.1007/BF00665790. Breast Cancer Res Treat. 1995. PMID: 7647335 Free article. Clinical Trial.

8

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.

Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: stoter g. Ann Oncol. 1995 Feb;6(2):190-2. doi: 10.1093/oxfordjournals.annonc.a059117. Ann Oncol. 1995. PMID: 7786826 Free article. Clinical Trial.

9

Weekly high-dose cisplatin in malignant pleural mesothelioma.

Planting AS, Schellens JH, Goey SH, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: stoter g. Ann Oncol. 1994 Apr;5(4):373-4. doi: 10.1093/oxfordjournals.annonc.a058846. Ann Oncol. 1994. PMID: 8075038 Free article. Clinical Trial.

10

Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site.

van der Gaast A, Henzen-Logmans SC, Planting AS, Stoter G, Verweij J. van der Gaast A, et al. Among authors: stoter g. Ann Oncol. 1993 Nov;4(9):789-90. doi: 10.1093/oxfordjournals.annonc.a058666. Ann Oncol. 1993. PMID: 8280660 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters